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Objectives: The concept of patency and limb salvage are physician-oriented endpoints in critical limb
ischaemia (CLI). These endpoints have failed to enhance function after revascularisation. The aim of this
study was to create a scoring system to predict 1-year functional status and to assess the beneﬁt to
patients possible by revascularisation.
Materials and methods: During the period 2007e2009, 480 consecutive patients (mean age  SD,
83.2  8.7 years) underwent repair for CLI. Preoperative, operative and functional status characteristics
and post-operative outcomes were recorded. The following patient-oriented outcomes were investigated
pre- and postoperatively: basic and instrumental activities of daily living (BADL and IADL) and ambu-
latory and living status. Statistical analysis was performed to assess predictors of functional beneﬁt from
revascularisation. The variables signiﬁcant on multivariable analysis were used to generate a scoring
system to pre and postoperatively grade individual patient risk of losing baseline functional status at 1
year (CLI functional score).
Results: Ninety-three of 480 patients (19.3%) were in Rutherford class IV, 208 (43.3%) in class V and 179
(37.4%) in class VI. Surgical, endovascular and hybrid operations were performed in 108 (22.5%), 319
(66.5%) and 53 (11%) patients, respectively; mean follow-up was 408  363 days. Improved or unchanged
functional status was observed in 276 patients (57.5%). Preoperative mean  SD BADL and IADL
(4.26  1.98 and 3.92  2.69, respectively) were modiﬁed from mean values at 1-year follow-up
(4.19  2.06 and 4.12  3, respectively) (p ¼ 0.401 and p < 0.05, respectively). In the same time
interval, mortality was 50%, limb salvage 50.4%, CLI-related new hospitalisations 50.8%, relief of symp-
toms 18.5% and tissue healing 14.5%. A CLI functional score of >80% indicates that patients are likely to
lose functional abilities and require assistance for ambulation or ADL, as well as risking outcomes such as
major amputation, new CLI-related hospitalisation or re-operation (p < 0.001). Preoperative poor living
status, dependence in daily activities, advanced local disease (lesion >2 cm, infection and poor tibial
runoff), American Society of Anesthesiologists (ASA) score > II, previous cerebrovascular event and heart
disease were the strongest pre-operative negative predictors of losing baseline functional status. Major
amputation was the only negative post-operative predictor.
Conclusions: Considering patient-oriented outcomes, our study showed that revascularisation could be
worthwhile in nearly 60% of CLI patients. A non-revascularisation strategy such as primary amputation or
palliation could be indicated in patients with a poor pre-operative living status, dependence for daily
activities, advanced local disease, extensive comorbid conditions and a score >80%. To make our ﬁndings
generalisable, the score needs to be validated in independent cohorts at different centres before it can be
recommended for application.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.ting (Athens), 23 September
: þ39 0577 233426.
ciety for Vascular Surgery. PublishCritical limb ischaemia (CLI) is the most advanced form of
peripheral arterial disease. It is associated with poor outcomes for
limb salvage, survival and unresolved pain and tissue loss and has
increasing social and economic costs.1e3 When reporting standards
for successful lower-extremity revascularisation were established,
it was assumed that arterial reconstruction, patency and limbed by Elsevier Ltd. All rights reserved.
Table 2
Patient data. ASA: American society of Anesthesiology; ADL: activities of daily
living; CAD: coronary artery disease; CAF: chronic atrial ﬁbrillation; CHF:
congestive heart failure; COPD: chronic obstructive pulmonary disease; renal
insufﬁciency: serum creatinine > 1.5 mg/dL; Hb: hemoglobin.
Variable n (%)
Pre-operative patient characteristics
Mean age  SD 83.2  8.7
Range (years) 54e93
Age > 80 years 472 (98.3)
Gender (male) 237 (49.4)
Current smoker 289 (60.2)
Statin therapy 236 (49.2)
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ultimate goal of therapy: improved functional performance and
preservation of ambulation.4,5 However physician-oriented
outcomes of revascularisation indicate failure to enhance patient
function.4,5 Patient expectations of vascular surgery are not just
limb salvage or a patent vessel, but functional limb salvage, inde-
pendence and ambulatory status (patient-oriented outcomes).4
Limb salvage may improve quality of life, survival and functional
status, but not all patients can endure it and therefore some CLI
patients are better off with primary amputation.6 Moreover, arterial
reconstruction patency is not necessarily correlated with limb
salvage.7,8 The most appropriate treatment for CLI (medical plus
reconstructive surgery or palliation/amputation) has become
controversial. The literature suggests that a standardised procedure
or scoring system could be useful for such decisions.9e11 The aim of
this study was to create a scoring system: (1) to predict 1-year
functional status after revascularisation and (2) to use patient-
oriented outcomes to select patients who beneﬁt from revascular-
isation and those for whom primary amputation or palliation
should be considered.CAD 281 (58.5)
Diabetes 252 (52.5)
Renal insufﬁciency 137 (28.5)
Dialysis 13 (2.7)
CAF 96 (20)
CHF 49 (10.2)
COPD 232 (48.3)
Beta blocker use 105 (21.9)
Obesity 56 (11.7)
Hypertension 402 (83.7)
Previous vascular intervention 213 (44.3)
Previous cerebrovascular event 73 (15.2)
Dementia 69 (14.4)
Contralateral limb loss 21 (4.4)
Hb <10 g/dL 104 (21.7)
Albumin <3 g/dL 85 (17.7)
Mono anti-platelet therapy 377 (78.5)
Dual anti-platelet therapy 81 (16.9)
Anticoagulant therapy 132 (27.5)
Prostanoid infusion 37 (7.7)
ASA classiﬁcation
I e
II 39 (8.1)
III 379 (78.9)
IV 62 (12.9)
Preoperative functional status
Ambulatory status
Independent 254 (53)
Assisted 207 (43.1)
Bedridden 19 (3.9)
Basic ADL >3 453 (94.3)
Instrumental ADL >4 224 (46.7)
Living status
Independent 271 (56.4)
Assisted 192 (40)
Nursing home 17 (3.6)
Lesion characteristics
Rutherford class IV 93 (19.3)
Rutherford class V 208 (43.3)Materials and Methods
Patient selection
From January 2007 to December 2009, all consecutive CLI
patients (Rutherford clinical categories: IVeVI)12 who underwent
repair at a single University tertiary referral centrewere included in
the study. Exclusion criteria were primary amputation,1 operative
death. Any acute limb ischaemia (symptoms onset 14 days)1 was
considered in the study period. All revascularisation procedures
were included for the analysis, regardless of speciﬁc inﬂow site,
outﬂow site and conduit or stent material/conﬁguration. The local
Ethical Committee approved the study, and the patients gave their
written informed consent to be included in the study.
The type of revascularisationwas left to the surgeon’s discretion,
which was based on extent, lesion type, anatomical factors
(previous ipsilateral bypass, inadequate greater saphenous vein or
leg ulcer preventing distal graft implantation) and general health
(poor health is an indication for endovascular treatment e see
Table 1). Revascularisation procedures were percutaneous endo-
vascular, hybrid and bypass graft repair (BG). Endovascular proce-
dures were carried out by conventional balloon angioplasty of the
target lesion with stent placement in the case of residual stenosis
>30% or ﬂow-limiting dissection. They were performed under local
anaesthesia with sedation as required. BG procedures were per-
formed according to standard vascular techniques, preferably using
an autologous vein. Hybrid procedures united endovascular and
surgical techniques to complete revascularisation in different
anatomical districts or to correct inadequate run-in or runoff. All
patients were treated by a vascular surgeon in an operating theatre
equipped with a portable ﬂuoroscopy unit (GE-OEC 9800; GETable 1
Deﬁnition of poor health status. FEV: forced expiratory volume.
Poor cardiac status:
e Unstable angina,
e Symptomatic or poorly controlled ectopy/arrhythmia,
e Poorly compensated or recurrent congestive heart failure,
e Ejection fraction less than 40%,
e Myocardial infarction within 6 months.
Poor pulmonary status:
e FEV 1 less than 1.2 L or less than 35% of predicted,
e Supplemental oxygen necessary,
e Pulmonary hypertension.Medical Systems, Salt Lake City, UT, USA). They underwent clinical
examination, ultrasound examination and assessment of ‘func-
tional status’ before treatment. Patient, lesion, operative variables,
medical therapy and pre-operative functional status were entered
in a database by the operating team (see Table 2). Data were
collected prospectively in a computerised database and analysed
retrospectively.Rutherford class VI 179 (37.4)
Lesion >2 cm 236 (49.2)
Infection 145 (30.2)
Operative characteristics
Urgent treatment 5 (1)
Inadequate run-in vessel 40 (8.3)
Patent profunda femoris 465 (96.9)
Run-off vessel peroneal artery 209 (43.3)
Run-off vessel posterior tibial artery 108 (22.5)
Run-off vessel anterior tibial artery 133 (27.7)
Symptom onset >1 month earlier 460 (95.8)
Type of treatment
Surgical 108 (22.5)
Hybrid 55 (11)
Endovascular 319 (66.5)
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Clinical outcomes were reported according to ‘Recommended
standards for reports’.12 Limb salvage was deﬁned as no amputation
proximal to the metatarsus. Technical success was deﬁned as
continuous patency of the treated artery without any obvious ﬂow-
limiting lesions. Wound-related revascularisation was deﬁned as
direct, continuous arterial patency to the region of the lesions.
Runoff vessel was deﬁned as a patent, crural vessel continuing from
the popliteal segment. In the case of aorto-iliac surgery, the patent
profunda femoris artery was considered as the runoff vessel.
Functional status was deﬁned by four parameters: Katz Index of
Independence in Activities of Daily Living (basic ADL),13
LawtoneBrody Index of Instrumental ADL (IADL),14 ambulatory
status and living status. Basic ADL (BADL) measures ability to
perform bathing, dressing, toileting, moving about, continence and
feeding independently, while IADL measures telephone use,
laundry, shopping, travel, planning, meal preparation, self-
medication, housekeeping and managing money. For BADL and
IADL score calculator, see http://cliscore.altervista.org. Patients
were scored from 0 to 1 (worst to best) for independence in each
function: score 0, unable to do activity and score 1, able to do
activity. Ambulatory status was assessed as ‘completely indepen-
dent’ (independent ambulation out of the house), ‘assisted’ and
‘bed-ridden’. Living status was deﬁned as ‘independent’ (indepen-
dent dwelling without external assistance), ‘assisted’ (assisted
living environment or a private residence with external assistance
for BADL) and ‘nursing home’. All functional status parameters
evaluated during follow-up were compared with those assessed
before onset of vascular symptoms. Short-term assisted living
during recovery was not considered loss of independence during
follow-up. Patients beneﬁtted from revascularisation when BADL,
IADL, ambulatory status and living status were preserved or
improved in at least three parameters at 1 year of follow-up.
Negative, positive and null factors for deterioration of functional
status after revascularisation, as at 1-year follow-up, were assessed.
A scoring system of pre-operative signiﬁcant predictors at multi-
variable analysis (patient, lesion, operative and functional-status
characteristics), was also generated and associated with
percentage loss of baseline function status at 1 year. The score was
designed to be adjusted and updated during follow-up by adding
post-operative outcomes.
Follow-up protocol
Two vascular surgeons (EC and AP) supervised the entire follow-
up. All patients underwent ipsilateral angiography on completion
of the procedure. Unless indicated earlier, ultrasound examination
was performed at 1, 3 and 6 months of follow-up, and every 6
months thereafter. All examinations were performed in the same
vascular laboratory, using the same ultrasound equipment (Ultra-
mark IU-22 and HDI 3500 ATL-Philips, Eindhoven, Holland). If
a patient did not present at the scheduled visit, a telephone inter-
view was performed, and the patient was scheduled for a clinical
visit within 1 month. Patient clinical and functional statuses were
evaluated at the same intervals.
Statistical analysis
The data were expressed as absolute frequencies and percent-
ages (%) or as means and standard deviations (SDs). All variables
were studied as binary variables. Preoperative and 1-year follow-up
characteristics for discrete variables were compared by Wilcoxon
signed-rank test for related samples. Associations between
outcomes and factors were evaluated by the chi-square test orFisher’s exact test. Variables yielding p values of less than 0.05 in
univariate analysis were entered into a stepwise multivariate
logistic regression. For each group of predictive variables (pre-
operative patient characteristics, pre-operative functional status,
lesion characteristics, operative characteristics and post-operative
outcomes), a different model was constructed to eliminate the
dependence of regressors. For this reason, we estimated ﬁve
different models. Odds ratios (ORs) and 95% conﬁdence intervals
(95% CIs) were calculated in each model and for each factor as
exponential of the variable coefﬁcient (beta). The risk score was
calculated by assigning scores (simple numerical scores: 0, þ1, etc.)
in relation to the estimated OR. A score was assigned to each
signiﬁcant variable. A web-based scoring system was developed
from these factors to predict the percentage probability of losing
baseline functional status at 1 year. The total score was the result of
the sum of the single scores (ss). To obtain a standardised score (CLI
score), it was necessary to adjust the total score according to its
minimum (min) and maximum (max) values:
CLIscore ¼
P
ssþ jminj
maxþ jminj*100:
Standardisation of total score enabled the probability of having
a certain 1-year functional status after revascularisation to be
expressed as percentage risk, facilitating interpretation of the
results. To assess the classiﬁcation score performance, receiver
operating curves (ROCs) with optimal speciﬁcity and sensitivity
levels were reported. KaplaneMeier survival analysis and life tables
were used to examine the distribution of post-operative outcomes
during follow-up. A p value <0.05 (two-tailed) was considered
statistically signiﬁcant. All analyses were performed by Statistical
Package for Social Sciences (SPSS) statistical software version 16
(SPSS Inc., Chicago, IL, USA).Results
General outcomes
A total of 497 patients suffering from CLI were seen at our
Institute. As many as 480 patients were revascularised in the study
period, and the remaining 17 (3.5%) patients met the exclusion
criteria (16 primary amputations and one intra-operative death).
All revascularised patients were included in the study, and their
details are shown in Table 2. The mean (SD) length of follow-up
was 408  363 days. No patients were lost to follow-up because
when scheduled clinical visits were missed (7%), a telephone
interview followed by a clinical visit was always arranged. In many
cases (73%), death was the reason for missed follow-up. More than
90% of patients were classiﬁed in class III or IV of the American
Society of Anesthesiology score (ASA), indicating the high-risk
status of the population. Nearly 80% of the population study
belonged to Rutherford classes V and VI, indicating very advanced
local disease. Surgical, endovascular and hybrid operations were
performed, respectively, in 108 (22.5%), 319 (66.5%) and 53 (11%)
patients. Technical success was similar in the three groups (95%
surgery, 91% endovascular and 94% hybrid), despite a relatively
higher failure rate in the endovascular group (p ¼ 0.27). Wound-
related revascularisation was obtained in 83.7% of patients
(without differences between groups, p ¼ 0.34). At 30-day follow-
up, the amputation rate was 2%, mortality 0.8%, CLI-related new
hospitalisation 20.8% and relief of symptoms and tissue healing 8%.
At 1-year follow-up, mortality was 50%, limb salvage 50.4% and CLI-
related new hospitalisations 50.8% (Fig. 1 e number of events
observed), whereas relief of symptoms and tissue healing were
18.5% and 14.5%, respectively.
Figure 1. KaplaneMeier plots and life tables of absence of major amputation, mortality and CLI-related new hospitalizations. CLI: critical limb ischemia.
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Variation in functional parameters from pre-operative to 1-year
follow-up is shown in Fig. 2. Preoperative mean (SD) BADL and
IADL were 4.26 1.98 and 3.92 2.69, respectively, compared with
4.19 2.06 and 4.12 3 at 1-year follow-up (p¼ 0.401 and p< 0.05,
respectively). -A total of 276 patients (57.5%) had obtained beneﬁt
from revascularisation during the ﬁrst year of follow-up. The other
204 patients, 155 (76%) of whomwere bed-ridden or dependent for
all ADLs, worsened in at least 2/4 functional status parameters
during the same time period.Figure 2. Variation of functional parameters from pre-operative to one-year follow-upPredictors of functional status
Positive, negative and null factors for post-operative modiﬁca-
tion of functional status are shown in Table 3A (univariate analysis).
Statistically signiﬁcant adjusted ORs were found for the following
predictors at multivariable analysis (Table 3B): (pre-operative
patient characteristics) statin therapy, coronary disease, congestive
heart failure, previous cerebrovascular event, haemoglobin
<10 g dl1, dual anti-platelet therapy, anticoagulant therapy,
ASA > II; (pre-operative functional status) BADL >3, IADL >4,
functional status assisted or nursing home; (lesion characteristics). BADL: basic activities of daily living, IADL: instrumental activities of daily living.
Table 3A
Negative, positive and null factors for deterioration of functional status after
revascularization at one-year follow-up (univariate analysis). FU: follow-up; ASA:
American society of Anesthesiology; ADL: activities of daily living; CAD: coronary
artery disease; CAF: chronic atrial ﬁbrillation; CHF: congestive heart failure; COPD:
chronic obstructive pulmonary disease; renal insufﬁciency: serum creatinine >
1.5 mg/dL; Hb: hemoglobin.
Functional
status at
one-year FU
Unchanged or
improved
(n ¼ 276) n (%)
Functional
status at
one-year FU
Deteriorated
(n ¼ 204) n (%)
p
Age > 80 years 268 (97.1) 204 (100) 0.139
Gender (male) 157 (56.5) 80 (39.2) <0.001
Current smokers 176 (63.8) 113 (55.4) 0.059
Statin therapy 172 (63.3) 64 (31.4) <0.001
CAD 136 (49.4) 145 (71.1%) <0.001
Diabetes 140 (50.6) 112 (54.9) 0.365
Renal insufﬁciency 80 (29) 57 (27.9) 0.712
Dialysis 8 (2.9) 5 (2.4) 0.515
CAF 40 (14.5) 56 (27.4) <0.001
CHF 12 (4.3) 37 (18.1) <0.001
COPD 140 (50.7) 92 (45.1) 0.223
Beta blocker use 68 (24.6) 37 (18.1) 0.066
Obesity 32 (11.6) 24 (11.8) 0.954
Hypertension 225 (81.5) 177 (86.8) 0.137
Previous vascular
intervention
113 (40.9) 100 (49) 0.066
Previous cerebrovascular
event
16 (5.8) 57 (27.9) <0.001
Dementia 20 (7.2) 49 (24) <0.001
Contralateral limb loss 9 (3.3) 12 (5.6) 0.106
Hb <10 g/dL 48 (17.4) 56 (27.4) <0.01
Albumin <3 g/dL 28 (10.1) 57 (28) <0.001
Mono anti-platelet therapy 241 (87.3) 136 (66.7) <0.001
Dual anti-platelet therapy 73 (26.4) 8 (3.9) <0.001
Anticoagulant therapy 48 (17.4) 84 (41.2) <0.001
Prostanoid infusion 20 (7.2) 17 (8.3) 0.806
ASA > II 240 (87) 201 (98.5) <0.001
Ambulatory status
(dependent or bed-ridden)
48 (17.4) 178 (87.2) <0.001
Basic ADL > 3 269 (97.4) 184 (90.2) 0.001
Instrumental ADL > 4 212 (76.8) 12 (5.9) <0.001
Living status (assisted
or nursing home)
48 (17.4) 161 (79) <0.001
Gangrene 48 (17.4) 128 (62.8) <0.001
Rutherford V 100 (36.2) 108 (53) <0.001
Rutherford VI 51 (18.5) 128 (62.7) <0.001
Lesion > 2 cm 84 (30.4) 152 (74.5) <0.001
Infection 32 (11.6) 113 (55.4) <0.001
Urgent treatment 0 5 (2.4) 0.05
Inadequate run-in vessel 16 (5.8) 24 (11.8) <0.05
Run-off vessel peroneal 133 (48.1) 76 (37.3) <0.05
Run-off vessel Posterior tibial 76 (27.5) 32 (15.6) <0.01
Run-off vessel Anterior tibial 97 (35.1) 36 (17.6) <0.001
Symptom onset > 1 month 260 (94.2) 200 (98) <0.05
Type of treatment
(endovascular or hybrid)
229 (82.3) 145 (71.1) <0.01
Wound related
revascularization
164 (59.4) 75 (36.8) <0.001
Absence of intra and
peri-operative
complications
236 (85.5) 108 (52.9) <0.001
Limb salvage 256 (92.7) 124 (60.8) <0.001
Major amputation 12 (4.3) 80 (39.2) <0.001
Minor amputation 60 (21.7) 56 (27.4) 0.148
Re-operation 152 (55.1) 148 (72.5) <0.001
Relief of symptoms 216 (78.3) 140 (68.6) <0.01
Tissue healing 156 (56.5) 124 (60.8) 0.452
Table 3B
Multivariable analysis of factors for deterioration of functional status after revas-
cularization at one-year follow-up and estimated scores for the various parameters
(CLI functional score). ASA: American society of Anesthesiology; ADL: activities of
daily living; CAD: coronary artery disease; CAF: chronic atrial ﬁbrillation; CHF:
congestive heart failure; COPD: chronic obstructive pulmonary disease; Hb:
hemoglobin.
p value OR (CI 95%) Score
Pre-operative patient characteristics
Gender (male) 0.079 e e
Statin therapy 0.022 0.50 (0.18e0.91) 1
CAD 0.010 2.03 (1.19e3.47) þ1
CAF 0.545 e e
CHF 0.026 2.52 (1.11e5.70) þ1
Previous cerebrovascular event <0.001 4.23 (1.93e9.27) þ2
Dementia 0.633 e e
Hb < 10 g/dL 0.029 2.00 (1.08e3.73) þ1
Albumin < 3 g/dL 0.112 e e
Mono anti-platelet therapy 0.456 e e
Dual anti-platelet therapy <0.001 0.17 (0.07e0.39) 3
Anticoagulant therapy <0.001 4.01 (2.39e6.74) þ2
ASA > II <0.001 8.71 (2.89e26.27) þ4
Preoperative functional status
Ambulatory status (dependent
or bed-ridden)
0.478 e e
Basic ADL > 3 0.018 0.27 (0.21e0.48) 2
Instrumental ADL > 4 <0.001 0.04 (0.02e0.07) 8
Living status (assisted or
nursing home)
<0.001 5.92 (2.33e15.04) þ3
Lesion characteristics
Gangrene 0.999 e e
Rutherford V 0.876 e e
Rutherford VI 0.999 e e
Lesion > 2 cm 0.007 2.18 (1.24e3.85) þ1
Infection 0.001 5.13 (3.02e8.73) þ2.5
Operative characteristics
Inadequate run-in vessel 0.001 3.58(1.71e7.49) þ2
Run-off vessel peroneal 0.279 e e
Run-off vessel Posterior tibial 0.004 0.48 (0.30e0.80) 1
Run-off vessel Anterior tibial <0.001 0.38 (0.24e0.61) 1.5
Symptom onset > 1 month 0.009 4.54 (1.46e14.11) þ2.5
Type of treatment (endovascular
or hybrid)
0.002 0.48 (0.30e0.76) 1
Post-operative outcomes
Wound related revascularization 0.629 e e
Absence of intra and peri-operative
complications
<0.001 0.25 (0.14e0.45) 2
Limb salvage 0.449 e e
Major amputation <0.001 7.42 (2.71e20.31) þ3.5
Re-operation 0.064 e e
Relief of symptoms 0.154 e e
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in vessel, anterior and posterior tibial runoff vessels, symptom
onset >1 month earlier, endovascular or hybrid treatment; and
(post-operative outcomes) no intra- and peri-operative complica-
tions, major amputation.CLI functional score
The CLI functional score of losing baseline functional status at
1-year of follow-up is shown in Table 3B, and a web-based score
calculator is available at http://cliscore.altervista.org. The presence
of any kind of complication or the occurrence of a major amputation
modiﬁes the pre-operative functional score during follow-up
(post-operative CLI functional score). The min and max values of
the CLI score were 19.5 and 25.5, respectively. The sensitivity and
speciﬁcity of each ROC curve of the scoring system with a cut-off at
80% ranged from 0.63 to 0.77 for sensitivity and from 0.72 to 0.87 for
speciﬁcity (for details see Table 4). The area under the curve was
signiﬁcant in all cases (p< 0.001). Patients scoring >80% were likely
to lose functional abilities (BADL and IADL) and become dependent
for ambulation or ADL, as well as outcomes such as major amputa-
tion, new CLI-related hospitalisation or re-operation (p < 0.001).
Discussion
To our knowledge, this is the ﬁrst article on scoring CLI
completely based on patient-related outcomes.4 The scoring
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is easy to use (available at: http://cliscore.altervista.org) and can be
updated during follow-up. It is not always easy to decide whether
to revascularise or amputate/palliate in cases of CLI. What counts
for patients is to maintain functional status, walking and inde-
pendence, obtain pain relief and avoid repeated and protracted
hospital admissions with second operations, wound complications
and unsuccessful revascularisation.6 Another aim was to help
physicians select treatment on the basis of pre-operative risk of
losing baseline functional status. For scores over 80%, revascular-
isation is unlikely to be successful and patients are likely to lose
functional abilities (BADL and IADL) and become dependent for
ambulation or daily activities, and may even risk a major ampu-
tation and a second CLI-related hospitalisation. On the basis
patient outcomes, nearly 40% of patients in this study did not
beneﬁt from revascularisation and worsened in at least 2/4 func-
tional parameters (BADL, IADL and ambulatory and living status) at
1-year follow-up. A signiﬁcant proportion ended up bed-ridden or
dependent for all daily activities. It is arguable if in this subgroup of
patients not beneﬁtting from revascularisation, an alternative
therapeutic approach such as primary amputation or palliation
would have resulted in a better functional outcome. However, the
other 60% achieved stabilised or even improved baseline func-
tional status at 1-year follow-up. This is not an insigniﬁcant
number, making the challenge to identify this subgroup worth-
while, so that resources can be focussed to improve CLI outcomes.
The need for vascular specialists will increase as the elderly pop-
ulation increases, making it even more important to focus on
patients who will beneﬁt from revascularisation. When revascu-
larisation is indicated, limb salvage is a major objective, as major
amputations dramatically impair functional status.4e6 It is not
surprising that major amputation was a strong negative predictor
in our study as well. Most patients requiring removal of the
calcaneus or other weight-bearing areas of the foot do not walk
independently even if revascularisation is successful. These
patients are more likely to walk with a prosthesis after a well-
planned amputation.15 Indeed, as highlighted by Taylor,6 ‘heroic
limb’ salvage is not feasible for everyone, because advanced local
disease and many comorbidities cancel out any advantages affor-
ded by limb revascularisation. According to our score, revascular-
isation is unlikely to bring any functional beneﬁt or stabilise
baseline status in patients with advanced local disease (lesion
>2 cm, infection and poor tibial runoff), severe comorbidities (ASA
score > II, previous cerebrovascular event and heart diseases) and
with poor living status. According to the literature, a major nega-
tive predictor for all outcomes, including functional ones, is poor
pre-operative living status.5,6,16e19 Some authors4,5,18,19 reported
that successful vascular treatment is not associated with improved
functional ability in patients with CLI, especially those already
dependent on aid for daily activities. In our opinion, when treating
such patients, even stabilisation of functional status can be
considered a success. A 60% outcome of stable and improved
patients therefore seems a good result. More blood to the foot does
not always appear to mean improved function because functional
status depends on many factors. Indeed, after endovascular or
surgical repair, no clinical improvement at mid-term follow-up has
been reported in nearly 10% of cases with a patent revascularised
artery.7,8
Other protective factors for functional outcome were found to
be statin and dual anti-platelet therapy. This emphasises the need
for up-to-date medical therapy for patients with CLI. The authors
strongly agree with Cieri et al.19 that nationwide preventive and
educational programmes should be implemented to prevent
severe, irreversible deterioration in CLI populations. CLI screening
could be helpful and even cost effective, because functionalimpairment is difﬁcult to reverse despite the possibility of
improving advanced limb ischaemia.4,5,7,17 The best management
of CLI patients should be prevention of advanced disease.19 In our
study, the type of treatment seemed related to functional
outcome; in fact, endovascular and hybrid procedures scored
better than BG. This may depend on prompt discharge of patients
and resumption of normal activities after endovascular treatment,
compared with a longer hospital stay after BG. Another point,
which may bias our study, is that endovascular treatment is ﬁrst
line, whereas BG is at least second line, though these data are at
variance with the literature.5,19 A good runoff situation is indeed
a protective factor for functional outcomes. Three well-designed
CLI scoring systems for operative risk have already been
proposed.9e11 The LEGS (Lower Extremity Grading System) score9
and the PREVENT III (Project of Ex Vivo Vein Graft Engineering via
Transfection III) CLI risk score10 evaluate some functional
outcomes. The major result of these scores was that lower-
extremity treatment standardisation can improve CLI patient
care.9e11 This is a possible strength of our scoring system. Patients
with CLI are extremely complex, and evaluation of their functional
status is even more complex. We used simple generic geriatric
health scales, namely the Katz BADL and LawtoneBrody IADL
indices, to obtain a thorough evaluation of our patients’ functional
ability.13,14 BADL and IADL indices are simple and inexpensive
instruments for creating a common language for patient function
and are therefore useful for studying the CLI population. They take
a global view of patient functional status and evaluate the true
impact of successful treatment of CLI on social health. In any case,
treatment should always be decided by vascular specialists on an
individual basis, evaluating the morbidity and mortality of revas-
cularisation or amputation against the likelihood of the desired
functional outcome. Our proposed score cannot replace this
complex clinical assessment and should only be considered an
auxiliary for therapeutic decisions. A number of questionnaires
and objective functional assessments are available in the literature,
but the optimal method of assessing intervention for CLI has yet to
be deﬁned.4 A paper from Shefﬁeld20 has stressed the concept that
the quality of life is an abstract phenomenon difﬁcult to summa-
rise in a single value, and this is mostly due to the fact that the
quality of each person’s life is dependent on factors such as
emotion, energy, pain, mobility and social functions. The complex
interplay of all these factors is responsible for a patient’s percep-
tion of the success or otherwise of their treatment. The quality of
life outcome is related more to the ability of returning a “healthy”
individual to his place in society than to saving an ischaemic
limb.20
Finally, the majority of the included patients had an advanced
local disease (80% Rutherford classes V or VI) with many comor-
bidities accounting for poor results as a high mortality and ampu-
tation rate combined with a low pain relief and tissue-healing rate.
The ‘rule’ of the more advanced the disease the poorer the
outcomes is herein respected.4e6,19
Limitations
The arithmetical formula has the intrinsic bias of being a rigid
measure to apply to CLI and its outcomes. Scores over 80% may be
considered reliable as sensitivity and speciﬁcity were insufﬁcient
below this threshold. Moreover, although this study involved quite
a large cohort of patients, it did not assess all the variables that may
have inﬂuenced functional outcomes, because the analysis lacked
the statistical power to adequately identify the relative importance
of other variables occurring at a low frequency in the study group.
Examples were the very low percentage of dialysis patients and
those younger than 80 years of age enrolled in the study. The
E. Chisci et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 540e547 547assessment of certain functional parameters was also subjective
and strictly related to the deﬁnitions used. Finally, patency and
analysis of costs were not included.
Conclusions
By considering patient-oriented outcomes, our study showed
that revascularisation could be worthwhile in nearly 60% of
patients with CLI. A non-revascularisation strategy such as primary
amputation or pain control and conservative wound management
could be indicated in patients with a poor pre-operative living
status, dependence for daily activities, advanced local disease
(lesion>2 cm, infection and poor tibial runoff), extensive comorbid
conditions (ASA score > II, previous cerebrovascular event and
heart disease) and a score >80%. To make our ﬁndings general-
isable, this scoring system needs to be validated in independent
cohorts at different centres before it can be recommended for
application.
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